EP3406608A1 — Therapeutically active compounds and their methods of use
Assigned to Les Laboratoires Servier SAS · Expires 2018-11-28 · 7y expired
What this patent protects
Provided are compounds being inhibitors of mutant IDH2 useful for treating cancer, methods for preparing such compounds and methods of treating cancer by administering to a subject in need thereof a compound described herein.
USPTO Abstract
Provided are compounds being inhibitors of mutant IDH2 useful for treating cancer, methods for preparing such compounds and methods of treating cancer by administering to a subject in need thereof a compound described herein.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.